• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天门冬氨酸氨基转移酶-血小板比值指数对乙型肝炎相关纤维化预测的诊断准确性:一项主要的荟萃分析。

Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis.

机构信息

Qingdao Municipal Hospital, Qingdao 266021, Shandong Province, China.

出版信息

BMC Gastroenterol. 2012 Feb 14;12:14. doi: 10.1186/1471-230X-12-14.

DOI:10.1186/1471-230X-12-14
PMID:22333407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3306191/
Abstract

BACKGROUND

The aspartate aminotransferase-to-platelet ratio index (APRI), a tool with limited expense and widespread availability, is a promising noninvasive alternative to liver biopsy for detecting hepatic fibrosis. The objective of this study was to systematically review the performance of the APRI in predicting significant fibrosis and cirrhosis in hepatitis B-related fibrosis.

METHODS

Areas under summary receiver operating characteristic curves (AUROC), sensitivity and specificity were used to examine the accuracy of the APRI for the diagnosis of hepatitis B-related significant fibrosis and cirrhosis. Heterogeneity was explored using meta-regression.

RESULTS

Nine studies were included in this meta-analysis (n = 1,798). Prevalence of significant fibrosis and cirrhosis were 53.1% and 13.5%, respectively. The summary AUCs of the APRI for significant fibrosis and cirrhosis were 0.79 and 0.75, respectively. For significant fibrosis, an APRI threshold of 0.5 was 84% sensitive and 41% specific. At the cutoff of 1.5, the summary sensitivity and specificity were 49% and 84%, respectively. For cirrhosis, an APRI threshold of 1.0-1.5 was 54% sensitive and 78% specific. At the cutoff of 2.0, the summary sensitivity and specificity were 28% and 87%, respectively. Meta-regression analysis indicated that the APRI accuracy for both significant fibrosis and cirrhosis was affected by histological classification systems, but not influenced by the interval between Biopsy & APRI or blind biopsy.

CONCLUSION

Our meta-analysis suggests that APRI show limited value in identifying hepatitis B-related significant fibrosis and cirrhosis.

摘要

背景

天冬氨酸氨基转移酶-血小板比值指数(APRI)是一种具有有限费用和广泛可用性的工具,是一种有前途的替代肝活检的非侵入性方法,用于检测肝纤维化。本研究的目的是系统地回顾 APRI 在预测乙型肝炎相关纤维化中的显著纤维化和肝硬化的表现。

方法

使用汇总受试者工作特征曲线下面积(AUROC)、敏感性和特异性来检查 APRI 对乙型肝炎相关显著纤维化和肝硬化的诊断准确性。使用荟萃回归探索异质性。

结果

本荟萃分析纳入了 9 项研究(n=1798)。显著纤维化和肝硬化的患病率分别为 53.1%和 13.5%。APRI 对显著纤维化和肝硬化的汇总 AUC 分别为 0.79 和 0.75。对于显著纤维化,APRI 阈值为 0.5 的敏感性为 84%,特异性为 41%。在截断值为 1.5 时,汇总敏感性和特异性分别为 49%和 84%。对于肝硬化,APRI 阈值为 1.0-1.5 的敏感性为 54%,特异性为 78%。在截断值为 2.0 时,汇总敏感性和特异性分别为 28%和 87%。荟萃回归分析表明,APRI 对显著纤维化和肝硬化的准确性受组织学分类系统的影响,但不受活检与 APRI 之间的间隔或盲法活检的影响。

结论

我们的荟萃分析表明,APRI 在识别乙型肝炎相关显著纤维化和肝硬化方面的价值有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9535/3306191/7d79fca2a10f/1471-230X-12-14-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9535/3306191/f3a2b77370de/1471-230X-12-14-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9535/3306191/157f3851dea8/1471-230X-12-14-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9535/3306191/fddf8fde5315/1471-230X-12-14-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9535/3306191/2972081318b9/1471-230X-12-14-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9535/3306191/7d79fca2a10f/1471-230X-12-14-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9535/3306191/f3a2b77370de/1471-230X-12-14-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9535/3306191/157f3851dea8/1471-230X-12-14-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9535/3306191/fddf8fde5315/1471-230X-12-14-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9535/3306191/2972081318b9/1471-230X-12-14-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9535/3306191/7d79fca2a10f/1471-230X-12-14-5.jpg

相似文献

1
Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis.天门冬氨酸氨基转移酶-血小板比值指数对乙型肝炎相关纤维化预测的诊断准确性:一项主要的荟萃分析。
BMC Gastroenterol. 2012 Feb 14;12:14. doi: 10.1186/1471-230X-12-14.
2
Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.天门冬氨酸氨基转移酶-血小板比值指数对丙型肝炎相关纤维化分期的诊断效能:一项更新的荟萃分析。
Hepatology. 2011 Mar;53(3):726-36. doi: 10.1002/hep.24105. Epub 2011 Feb 11.
3
Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review.天冬氨酸氨基转移酶与血小板比值指数预测丙型肝炎相关纤维化的诊断准确性:一项系统评价
Hepatology. 2007 Sep;46(3):912-21. doi: 10.1002/hep.21835.
4
Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis.天门冬氨酸氨基转移酶血小板比值指数和纤维化-4 指数对慢性乙型肝炎病毒感染成人患者肝纤维化检测的诊断准确性比较:系统评价和荟萃分析。
Hepatology. 2015 Jan;61(1):292-302. doi: 10.1002/hep.27382. Epub 2014 Nov 24.
5
Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B.天冬氨酸转氨酶与血小板比值可减少中国慢性乙型肝炎患者对瞬时弹性成像的需求。
Medicine (Baltimore). 2019 Dec;98(49):e18038. doi: 10.1097/MD.0000000000018038.
6
Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection.丙型肝炎病毒与血吸虫病合并感染时的天冬氨酸转氨酶与血小板比值指数
World J Gastroenterol. 2015 Dec 14;21(46):13132-9. doi: 10.3748/wjg.v21.i46.13132.
7
Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B.预测慢性乙型肝炎显著纤维化和肝硬化的血清生物标志物
J Clin Gastroenterol. 2015 Sep;49(8):705-13. doi: 10.1097/MCG.0000000000000250.
8
Validation of aspartate aminotransferase to platelet ratio for diagnosis of liver fibrosis and prediction of postoperative prognosis in infants with biliary atresia.天冬氨酸氨基转移酶与血小板比值在诊断胆道闭锁婴儿肝纤维化及预测术后预后中的验证
World J Gastroenterol. 2015 May 21;21(19):5893-900. doi: 10.3748/wjg.v21.i19.5893.
9
Noninvasive Models for Predicting Liver Fibrosis in Individuals with Hepatitis D Virus/Hepatitis B Virus Coinfection in the Brazilian Amazon Region.巴西亚马逊地区乙型肝炎病毒/丁型肝炎病毒合并感染个体肝纤维化无创模型预测。
Am J Trop Med Hyg. 2020 Jul;103(1):169-174. doi: 10.4269/ajtmh.19-0688. Epub 2020 May 14.
10
Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection.逐步应用基于四个因素、红细胞分布宽度-血小板比值和天冬氨酸氨基转移酶-血小板比值的纤维化指数检测代偿性乙型肝炎纤维化。
J Gastroenterol Hepatol. 2018 Jan;33(1):256-263. doi: 10.1111/jgh.13811.

引用本文的文献

1
Investigation of Hepatitis C, D, and HIV Seroprevalence and Evaluation of APRI and FIB-4 Scores in HbsAg-Positive Patients.乙肝表面抗原阳性患者丙型肝炎、丁型肝炎和艾滋病毒血清流行率调查及APRI和FIB-4评分评估
Viruses. 2025 Apr 15;17(4):568. doi: 10.3390/v17040568.
2
Efficacy of [Ga]Ga-FAPI-PET as a non-invasive evaluation method of liver fibrosis.[镓]镓-FAPI-PET作为肝纤维化无创评估方法的疗效
Ann Nucl Med. 2025 Jun;39(6):631-639. doi: 10.1007/s12149-025-02027-6. Epub 2025 Mar 6.
3
Prediction of hepatic fibrosis using the aspartate transaminase-to-platelet ratio index in children and adolescents with metabolic dysfunction-associated steatotic liver disease.

本文引用的文献

1
Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: a comparative study.基于组合预测模型对慢性乙型肝炎肝纤维化分期的比较研究。
World J Gastroenterol. 2010 Jan 28;16(4):501-7. doi: 10.3748/wjg.v16.i4.501.
2
Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis.轻度肝硬化和血清HBeAg转阴并不意味着乙肝相关肝硬化患者发生肝细胞癌的风险较低。
Med Sci Monit. 2009 Jun;15(6):CR274-9.
3
APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology.
应用天门冬氨酸氨基转移酶/血小板比值指数预测代谢相关脂肪性肝病患儿肝纤维化。
BMC Pediatr. 2024 Nov 30;24(1):788. doi: 10.1186/s12887-024-05263-3.
4
A Clinical Review of Noninvasive Tests for Hepatic Fibrosis.肝纤维化无创检测的临床综述
Gastroenterol Hepatol (N Y). 2024 Aug;20(6):322-329.
5
KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease.KASL慢性肝病肝纤维化评估无创检测临床实践指南。
Clin Mol Hepatol. 2024 Sep;30(Suppl):S5-S105. doi: 10.3350/cmh.2024.0506. Epub 2024 Aug 19.
6
FibroScan versus Biochemical Scores: A Study of Liver Fibrosis in HIV with HBV Co-Infection.FibroScan与生化评分:一项关于合并HBV感染的HIV患者肝纤维化的研究。
Microorganisms. 2024 Jun 16;12(6):1213. doi: 10.3390/microorganisms12061213.
7
APRI as a predictor of severe dengue fever.APRI作为重症登革热的预测指标。
J Family Med Prim Care. 2024 Feb;13(2):613-618. doi: 10.4103/jfmpc.jfmpc_1127_23. Epub 2024 Mar 6.
8
Noninvasive Methods for Assessing Liver Fibrosis and Steatosis.评估肝纤维化和脂肪变性的非侵入性方法
Gastroenterol Hepatol (N Y). 2024 Jan;20(1):21-29.
9
Non-Invasive Prediction Scores for Hepatitis B Virus- and Hepatitis D Virus-Infected Patients-A Cohort from the North-Eastern Part of Romania.罗马尼亚东北部乙型肝炎病毒和丁型肝炎病毒感染患者的无创预测评分——一项队列研究
Microorganisms. 2023 Nov 30;11(12):2895. doi: 10.3390/microorganisms11122895.
10
The role of preoperative aspartate aminotransferase-to-platelet ratio index in predicting complications following total hip arthroplasty.术前天门冬氨酸氨基转移酶/血小板比值指数在全髋关节置换术后并发症预测中的作用。
BMC Musculoskelet Disord. 2023 Dec 2;24(1):934. doi: 10.1186/s12891-023-07063-9.
APRI和FIB-4评分在肝移植后不论病因均具有实用性。
Transplant Proc. 2009 Mar;41(2):679-81. doi: 10.1016/j.transproceed.2008.12.014.
4
[A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].[一种预测慢性乙型肝炎患者组织学肝硬化的非侵入性模型]
Zhonghua Gan Zang Bing Za Zhi. 2009 Jan;17(1):28-32.
5
Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B.慢性乙型肝炎患者联合血清转氨酶/血小板比值指数和透明质酸对肝纤维化的无创评估
World J Gastroenterol. 2008 Dec 14;14(46):7117-21. doi: 10.3748/wjg.14.7117.
6
Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B.FibroScan在慢性乙型肝炎早期代偿期肝硬化检测中的应用价值
Dig Dis Sci. 2009 Aug;54(8):1758-63. doi: 10.1007/s10620-008-0541-2. Epub 2008 Nov 13.
7
Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases.用于测量肝脏硬度值的瞬时弹性成像技术能够检测出日本病毒性和非病毒性肝病患者早期的显著肝纤维化。
J Gastroenterol. 2008;43(9):720-8. doi: 10.1007/s00535-008-2225-2. Epub 2008 Sep 20.
8
Disease progression and the risk factor analysis for chronic hepatitis C.慢性丙型肝炎的疾病进展及危险因素分析
Liver Int. 2008 Dec;28(10):1363-9. doi: 10.1111/j.1478-3231.2008.01860.x.
9
Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.回顾性评估血清标志物APRI和AST/ALT在慢性乙型和丙型肝炎合并肝细胞癌患者中评估肝纤维化和肝硬化的价值。
Intern Med. 2008;47(7):569-75. doi: 10.2169/internalmedicine.47.0595. Epub 2008 Apr 1.
10
Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.优化的临界值可提高天冬氨酸转氨酶与血小板比值指数在预测人类免疫缺陷病毒/丙型肝炎病毒合并感染患者显著肝纤维化方面的性能。
Liver Int. 2008 Apr;28(4):486-93. doi: 10.1111/j.1478-3231.2008.01675.x.